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NETTER TO THE EDITOR
lostridium  difﬁcile  in  Libya:
 neglected  pathogen?
ear  Editor,
Clostridium  difﬁcile  is  a  leading  cause  of
ospital-associated  and  antimicrobial-associated
iarrhea  [1,2].  Clinical  and  epidemiological
hanges  have  been  associated  with  dissemination
f hypervirulent  clones,  particularly  ribotype  027
3].  C.  difﬁcile  infection  (CDI)  has  been  reported
hroughout much  of  the  world,  mainly  from  West-
rn countries  in  the  last  two  decades.  Limited
nformation is  in  the  Middle  Eastern  countries,  or
bout C.  difﬁcile  strains  that  are  involved.
There  is no  information  on  the  status  of  CDI
n Libyan  healthcare  settings  and  its  true  preva-
ence remains  unknown.  Therefore,  it  is  necessary
o address  all  the  issues  related  to  CDI  that  include:
he prevalence  rates  and  its  ribotypes,  to  assess
wareness among  physicians,  potential  risk  fac-
ors that  may  contribute  to  CDI  and  to  provide  a
eliable epidemiologically-based  conclusion  of  this
mportant  disease.  Such  information  is ultimately
aluable to  develop  appropriate  strategies  to  pre-
ent CDI  and  the  vast  negative  impact  of  such
nfections in  Libya.  Currently,  none  of  the  health-
are setting  has  the  capacity  and  resources  to
etect C.  difﬁcile  because  it  is  not  part  of  national
etection system.  This  challenge  must  be  seriously
ddressed  by  all  health  care  institutions  by  estab-
ishing  a  proper  detection  system  to  monitor  and
eport  the  prevalence  of  C.  difﬁcle  to  deﬁne  the
agnitude  of  the  problem  locally,  regionally  and
ationally.  The  currently  recommended  two-step
lgorithm  can  be  consistently  introduced;  regard-
ess of  whether  testing  a  small  or  large  serious
f samples  or  single  samples  using  a  rapid  test.
 rapid  cassette  test  that  simultaneously  detects
oth glutamate  dehudrogenase  antigen  and  toxins
 and  B is  a  suitable  and  simple  assay  that  can  bePlease  cite  this  article  in  press  as:  Zorgani  A,  Elzouki  A-N.  
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arried  out  in  all  suspected  cases  as  a  screening
ethod for  the  presence  of  C.  difﬁcile  in  fecal  spec-
mens.  In addition,  to  determine  the  emergence  of
E
N
ttp://dx.doi.org/10.1016/j.jiph.2016.05.005
876-0341/© 2016 King Saud Bin Abdulaziz University for Health Sciehe  hypervirulent  ribotype  027  (NAP1  and  REA  type
I) strain  or  other  circulating  strains  in  order  to
stablish  the  burden  of  this  disease  that  should  be
stablished  at  the  reference  laboratory  of  National
entre  of  Diseases  Control  (NCDC).
The awareness  of  antibiotic  resistance  and  its
ssociation  with  CDI  among  healthcare  providers  is
oor and  the  majority  of  infectious  disease  spe-
ialists understand  that  CDI  should  be  included  in
he routine  differential  diagnoses  for  hospitalized
atients presenting  with  diarrhea.  The  clinicians
eed to  maintain  a  high  index  of  suspicion  for  CDI
nd there  is also  a need  for  continuous  educa-
ional programs  should  be  directed  to  all  clinicians
oncerning the  role  of  C.  difﬁcile  as  an  impor-
ant enteric  pathogen  especially  in  hospitalized
atients. At  the  same  time,  over  prescription
nd non-prescribe  antibiotic  is  high  in  Libya  [4].
he use  of  certain  antibiotics,  especially  ﬂuoro-
uinolones, third  generation  cephalosporins  and
iperacillin/tazobactam  has  been  linked  to  devel-
pment  of  CDI  [5—7]. Clindamycin  are  considered  to
e high  risk  antibiotics  and  the  main  drivers  of  CDI,
lindamycin  is  not  available  in  Libya.  Therefore,
t is important  to  develop  strategies  to  prevent  C.
ifﬁcile infections  by  good  adherence  to  infection
ontrol measures  and  to  screen  adult  hospitalized
atients for  presence  of  CDI  and  its  toxins  and
ntimicrobial resistance  patterns.
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